GlaxoSmithKline PLC GSK Blocklisting Interim Review

  GlaxoSmithKline PLC (GSK) - Blocklisting Interim Review

RNS Number : 7120Q
GlaxoSmithKline PLC
08 November 2012










                       BLOCK LISTING SIX MONTHLY RETURN



Information provided on this form must be typed or printed electronically and
provided to an ris.



Date: 8 November 2012



Name of applicant:                           GlaxoSmithKline plc
Name of scheme:                              GlaxoSmithKline Share Option Plan
                                             - Ordinary Shares
Period of return:             From:          1 May 2012    To:    31 October
                                                                  2012
Balance of unallotted securities under       14,090,687
scheme(s) from previous return:
Plus: The amount by which the block
scheme(s) has been increased since the date  0
of the last return (if any increase has been
applied for):
Less: Number of securities issued/allotted
under scheme(s) during period (see           4,373,486
LR3.5.7G):
Equals: Balance under scheme(s) not yet     9,717,201
issued/allotted at end of period:



Name of contact:             Victoria Whyte
Telephone number of contact: 020 8047 5000













                       BLOCK LISTING SIX MONTHLY RETURN



Information provided on this form must be typed or printed electronically and
provided to an ris.



Date: 8 November 2012



Name of applicant:                                GlaxoSmithKline plc
Name of scheme:                                   GlaxoSmithKline Share Option
                                                  Plan - ADS
Period of return:                 From:           1 May 2012  To:  31 October
                                                                   2012
Balance of unallotted securities under scheme(s)  5,537,568
from previous return:
Plus: The amount by which the block scheme(s)
has been increased since the date of the last     10,000,000
return (if any increase has been applied for):
Less: Number of securities issued/allotted under 7,175,490
scheme(s) during period (see LR3.5.7G):
Equals: Balance under scheme(s) not yet          8,362,078
issued/allotted at end of period:



Name of contact:             Victoria Whyte
Telephone number of contact: 020 8047 5000









                       BLOCK LISTING SIX MONTHLY RETURN



Information provided on this form must be typed or printed electronically and
provided to an ris.



Date: 8 November 2012



Name of applicant:                              GlaxoSmithKline plc
Name of scheme:                                 Glaxo Wellcome UK Share Option
                                                Scheme
Period of return:               From:           1 May 2012   To:   31 October
                                                                   2012
Balance of unallotted securities under          5,119,750
scheme(s) from previous return:
Plus: The amount by which the block scheme(s)
has been increased since the date of the last   0
return (if any increase has been applied for):
Less: Number of securities issued/allotted     0
under scheme(s) during period (see LR3.5.7G):
Equals: Balance under scheme(s) not yet        5,119,750
issued/allotted at end of period:



Name of contact:             Victoria Whyte
Telephone number of contact: 020 8047 5000















                       BLOCK LISTING SIX MONTHLY RETURN



Information provided on this form must be typed or printed electronically and
provided to an ris.



Date: 8 November 2012



Name of applicant:                          GlaxoSmithKline plc
Name of scheme:                             Glaxo Wellcome International Share
                                            Option Scheme
Period of return:            From:          1 May 2012    To:    31 October
                                                                 2012
Balance of unallotted securities under      13,267,156
scheme(s) from previous return:
Plus: The amount by which the block
scheme(s) has been increased since the date 0
of the last return (if any increase has
been applied for):
Less: Number of securities issued/allotted
under scheme(s) during period (see          0
LR3.5.7G):
Equals: Balance under scheme(s) not yet    13,267,156
issued/allotted at end of period:



Name of contact:             Victoria Whyte
Telephone number of contact: 020 8047 5000

















                       BLOCK LISTING SIX MONTHLY RETURN



Information provided on this form must be typed or printed electronically and
provided to an ris.



Date: 8 November 2012



Name of applicant:                            GlaxoSmithKline plc
Name of scheme:                               Glaxo Wellcome 1999 Share Option
                                              Plan
Period of return:             From:           1 May 2012    To:   31 October
                                                                  2012
Balance of unallotted securities under        1,040,000
scheme(s) from previous return:
Plus: The amount by which the block
scheme(s) has been increased since the date   0
of the last return (if any increase has been
applied for):
Less: Number of securities issued/allotted   0
under scheme(s) during period (see LR3.5.7G):
Equals: Balance under scheme(s) not yet      1,040,000
issued/allotted at end of period:



Name of contact:             Victoria Whyte
Telephone number of contact: 020 8047 5000















                       BLOCK LISTING SIX MONTHLY RETURN



Information provided on this form must be typed or printed electronically and
provided to an ris.



Date: 8 November 2012



Name of applicant:                           GlaxoSmithKline plc
Name of scheme:                              SmithKline Beecham 1989 Executive
                                             Share Option Plan - Approved -
                                             Ordinary Shares
Period of return:              From:         1 May 2012    To:    31 October
                                                                  2012
Balance of unallotted securities under       163,606
scheme(s) from previous return:
Plus: The amount by which the block
scheme(s) has been increased since the date  0
of the last return (if any increase has been
applied for):
Less: Number of securities issued/allotted
under scheme(s) during period (see           0
LR3.5.7G):
Equals: Balance under scheme(s) not yet     163,606
issued/allotted at end of period:



Name of contact:             Victoria Whyte
Telephone number of contact: 020 8047 5000















                       BLOCK LISTING SIX MONTHLY RETURN



Information provided on this form must be typed or printed electronically and
provided to an ris.



Date: 8 November 2012



Name of applicant:                        GlaxoSmithKline plc
Name of scheme:                           SmithKline Beecham 1989 Executive
                                          Share Option Plan - Unapproved - ADS
Period of return:           From:         1 May 2012     To:     31 October
                                                                 2012
Balance of unallotted securities under    275,420
scheme(s) from previous return:
Plus: The amount by which the block
scheme(s) has been increased since the    0
date of the last return (if any increase
has been applied for):
Less: Number of securities
issued/allotted under scheme(s) during    0
period (see LR3.5.7G):
Equals: Balance under scheme(s) not yet  275,420
issued/allotted at end of period:



Name of contact:             Victoria Whyte
Telephone number of contact: 020 8047 5000















                       BLOCK LISTING SIX MONTHLY RETURN



Information provided on this form must be typed or printed electronically and
provided to an ris.



Date: 8 November 2012



Name of applicant:                           GlaxoSmithKline plc
Name of scheme:                              SmithKline Beecham 1989 Executive
                                             Share Option Plan - Unapproved -
                                             Ordinary
Period of return:              From:         1 May 2012    To:    31 October
                                                                  2012
Balance of unallotted securities under       100,000
scheme(s) from previous return:
Plus: The amount by which the block
scheme(s) has been increased since the date  0
of the last return (if any increase has been
applied for):
Less: Number of securities issued/allotted
under scheme(s) during period (see           0
LR3.5.7G):
Equals: Balance under scheme(s) not yet     100,000
issued/allotted at end of period:



Name of contact:             Victoria Whyte
Telephone number of contact: 020 8047 5000















                       BLOCK LISTING SIX MONTHLY RETURN



Information provided on this form must be typed or printed electronically and
provided to an ris.



Date: 8 November 2012



Name of applicant:                             GlaxoSmithKline plc
Name of scheme:                                GlaxoSmithKline Savings Related
                                               Share Option Scheme
Period of return:               From:          1 May 2012   To:   31 October
                                                                  2012
Balance of unallotted securities under         4,005,708
scheme(s) from previous return:
Plus: The amount by which the block scheme(s)
has been increased since the date of the last  0
return (if any increase has been applied for):
Less: Number of securities issued/allotted    115,727
under scheme(s) during period (see LR3.5.7G):
Equals: Balance under scheme(s) not yet       3,889,981
issued/allotted at end of period:



Name of contact:             Victoria Whyte
Telephone number of contact: 020 8047 5000











                     This information is provided by RNS
           The company news service from the London Stock Exchange

END


BLRBRBDBRDGBGDI -0- Nov/08/2012 17:28 GMT